LCM Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $824K | Buy |
2,031
+5
| +0.2% | +$2.03K | 0.43% | 41 |
|
|
2025
Q1 | $1.01M | Buy |
2,026
+58
| +3% | +$28.9K | 0.59% | 33 |
|
|
2024
Q4 | $1.02M | Buy |
1,968
+5
| +0.3% | +$2.6K | 0.58% | 32 |
|
|
2024
Q3 | $1.21M | Buy |
1,963
+50
| +3% | +$30.9K | 0.7% | 29 |
|
|
2024
Q2 | $1.06M | Buy |
1,913
+35
| +2% | +$19.4K | 0.66% | 28 |
|
|
2024
Q1 | $1.09M | Buy |
1,878
+11
| +0.6% | +$6.39K | 0.71% | 28 |
|
|
2023
Q4 | $991K | Buy |
1,867
+1
| +0.1% | +$531 | 0.72% | 26 |
|
|
2023
Q3 | $945K | Buy |
1,866
+107
| +6% | +$54.2K | 0.77% | 22 |
|
|
2023
Q2 | $918K | Buy |
1,759
+26
| +2% | +$13.6K | 0.75% | 24 |
|
|
2023
Q1 | $999K | Buy |
1,733
+108
| +7% | +$62.2K | 0.87% | 19 |
|
|
2022
Q4 | $895K | Buy |
1,625
+13
| +0.8% | +$7.16K | 0.87% | 21 |
|
|
2022
Q3 | $818K | Sell |
1,612
-5
| -0.3% | -$2.54K | 0.86% | 19 |
|
|
2022
Q2 | $878K | Sell |
1,617
-13
| -0.8% | -$7.06K | 0.86% | 19 |
|
|
2022
Q1 | $963K | Buy |
1,630
+23
| +1% | +$13.6K | 0.78% | 23 |
|
|
2021
Q4 | $1.07M | Buy |
1,607
+77
| +5% | +$51.4K | 0.83% | 22 |
|
|
2021
Q3 | $874K | Sell |
1,530
-14
| -0.9% | -$8K | 0.74% | 21 |
|
|
2021
Q2 | $779K | Buy |
1,544
+19
| +1% | +$9.59K | 0.65% | 26 |
|
|
2021
Q1 | $696K | Sell |
1,525
-83
| -5% | -$37.9K | 0.62% | 30 |
|
|
2020
Q4 | $750K | Buy |
+1,608
| New | +$750K | 0.71% | 24 |
|